NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

So what you are contemplating is that the "Medical Arts" in treating patients in the oncology clinics with DVAX-L for other cancers will be supported, confirmed and informed by the "Medical Sciences" in that some of these oncology clinics will be running clinical trials using external controls (all patients treated with DVAX-L). Therefore the treatment protocols as first deduced by the Art of the treating Physicians are advanced and refined by the Scientific Method of analysis of the outcomes and progress of all of these patients case studies taken as a whole and grouped according the relevant permutations or factors. In effect what starts as treating many patients with various solid tumors could rapidly result in most patients treated with DVAX-L if effectacious as the Medical Art and Science of DVAX-L evolve together.